Persimmon leaf extract supports blood pressure and cholesterol in recent study
A recently published study found that supplementation with a proprietary persimmon leaf extract from Nutraceuticals & Agriceuticals Technology Company (NATCO), called Persimonal, may support blood pressure and healthy cholesterol.
Photo © AdobeStock.com/ valery121283
A recently published randomized, placebo-controlled study1 found that supplementation with a proprietary persimmon leaf extract from Nutraceuticals & Agriceuticals Technology Company (NATCO), called Persimonal, may support blood pressure and healthy cholesterol. In the study, 86 male and female subjects between the ages of 40 and 75 years with borderline hypertension or borderline high total cholesterol or LDL were enrolled and assigned to take two capsules daily (150 mg in each capsule) of either the persimmon leaf extract or placebo for 180 days. Subjects were evaluated at baseline, day 7, 30, 60, 90, 120, 150 and 180 to get a blood pressure test or blood draw, or both, depending on their initial health evaluation. Subjects also get a diary. Of the 86 subjects, 73 completed the study.
Results showed that subjects assigned to receive the persimmon leaf extract saw a statistically significant reduction in mean blood pressure values compared to baseline at all study assessment timepoints for systolic and diastolic blood pressure, except day 7 for diastolic blood pressure. When it came to lipid profiles, subjects taking the persimmon leaf extract saw statistically significant reductions in the mean LDL and in mean total cholesterol compared to baseline at day 7, 60, 90, and 120 for LDL, and days 7, 30, and 120 for total cholesterol.
"We are pleased to announce these positive results of Persimonal to reduce blood pressure and lipids in the blood, further expanding our excitement about this high-quality product. It is no wonder persimmon leaves have been an essential part of traditional medicine in Asia for centuries," said Abdul Alkayali, co-founder and executive vice president of NATCO, in a press release.
Reference
- Bagatela, B.S.; Lopes, I.P.; Fonseca, F.L.A.; Lopes, A.P. The Effects of a Persimmon Leaf Oral Supplement (Persimonal®) on Cardiovascular Health: A Randomized, Double-Blinded, Placebo-Controlled Study. HealthMED. 2023, 17 (1): 3-13
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
